Market access is a critical function of a drug’s go-to-market strategy, as it sets the stage for a successful debut. In the months before launch, your market access team must lay the groundwork for your drug’s pricing, contracting, reimbursement and fulfillment strategies.
Post-launch uptake depends on how well your team can define and communicate your brand’s clinical and economic value to payers, providers and patients. In this webinar, we’ll explain how and when to initiate each market access step in the year before launch.
You will learn:
If you haven’t already, be sure to watch the recording of our first webinar in this series, Strategies for Early Market Access Planning.
Ryan Witherington
Senior Consultant
Ryan Witherington is a solution consultant at MMIT. Ryan works with new and existing clients to provide gold-standard demonstrations using his extensive industry expertise and product knowledge. For more than a decade, Ryan has served in various roles in healthcare intelligence, from research analyst to associate director of customer success. He holds a Bachelor of Business Administration degree from Belmont University.
Carolyn Zele
Advisor for MMIT’s Solution Consulting Team
Carolyn Zele is an advisor for MMIT’s solution consulting team who helps pharmaceutical manufacturers simplify market access and prepare for launch success. Prior to MMIT, Carolyn spent numerous years in the payer/PBM space managing formulary teams and technology across both regulated and non-regulated lines of business. She holds a Master of Science degree from Colorado State University.
